Cigna Group $CI Stock: Sanders Capital LLC Trims Holdings

Sanders Capital LLC decreased its position in shares of Cigna Group (NYSE:CI) by 0.5% during the 3rd quarter, Holdings Channel.com reports. The fund owned 10,098,076 shares of the health services provider’s stock after selling 46,541 shares during the period. Cigna Group makes up 2.7% of Sanders Capital LLC’s holdings, making the stock its 10th largest holding. Sanders Capital LLC’s holdings in Cigna Group were worth $2,744,960,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also modified their holdings of the company. GQG Partners LLC acquired a new stake in Cigna Group in the second quarter valued at $1,628,918,000. Bank of America Corp DE acquired a new position in shares of Cigna Group during the 2nd quarter worth $827,692,000. Legal & General Group Plc purchased a new stake in shares of Cigna Group in the 2nd quarter worth about $542,779,000. The Manufacturers Life Insurance Company purchased a new stake in shares of Cigna Group in the 2nd quarter worth about $241,312,000. Finally, BlackRock Inc. boosted its position in shares of Cigna Group by 3.7% in the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after buying an additional 840,098 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
• Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
• Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
• Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

Cigna Group Trading Down 2.6%

Cigna Group stock traded down $7.82 during trading on Friday, reaching $293.66. The company had a trading volume of 2,427,984 shares, compared to its average volume of 1,441,425. Cigna Group has a 12-month low of $255.53 and a 12-month high of $318.05. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock’s 50 day moving average price is $285.81 and its two-hundred day moving average price is $282.17. The firm has a market capitalization of $77.60 billion, a price-to-earnings ratio of 12.96, a PEG ratio of 1.00 and a beta of 0.25.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. The firm had revenue of $73.79 billion for the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The firm’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same quarter last year, the firm earned $7.83 earnings per share. As a group, equities analysts expect that Cigna Group will post 30.52 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date is Thursday, December 3rd. Cigna Group’s payout ratio is currently 25.82%.

Insider Activity at Cigna Group

In other news, insider Nicole Jones sold 2,677 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the firm’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

CI has been the topic of a number of research reports. UBS Group reissued a “buy” rating on shares of Cigna Group in a research note on Thursday, October 1st. Raymond James Financial downgraded shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price target for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Barclays increased their price target on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Royal Bank Of Canada reiterated an “outperform” rating and issued a $337.00 price target on shares of Cigna Group in a research report on Thursday, October 1st. Finally, Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research note on Friday, July 31st. Fourteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $335.70.

About Cigna Group

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.